Oncologix Tech Inc. announced that it has closed on a $4,000,000 revolving line of credit. Under the terms of the agreement, TCA Global Credit Master Fund, L.P. committed to lend $4,000,000 through one of the Fund's Senior Secured Revolving Notes, with an initial draw of $500,000. The company must meet specific monthly reporting and collateral requirements to further draw on the revolving credit facility.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+176.46% | 6.96B | |
+2.19% | 982M | |
+41.91% | 872M | |
+31.32% | 830M | |
+1.72% | 664M | |
+5.92% | 642M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- OCLG Stock
- News Oncologix Tech, Inc.
- Oncologix Tech Inc. Closes $4,000,000 Revolving Credit Facility from Senior Lender